Recombinant Human Insulin Production Cost Reports
Healthcare
The report provides a detailed analysis essential for establishing a recombinant human insulin manufacturing plant. It encompasses all critical aspects necessary for recombinant human insulin production, including the cost of recombinant human insulin production, recombinant human insulin plant cost, recombinant human insulin production costs, and the overall recombinant human insulin manufacturing plant cost.
Additionally, the study covers specific expenditures associated with setting up and operating a recombinant human insulin production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Recombinant Human Insulin is a genetically engineered peptide hormone manufactured on a large scale by recombinant DNA (rDNA) technology for various medicinal purposes. Its primary application involves its usage in controlling blood sugar levels in patients with diabetes via insulin therapy.
It is widely utilized as a key supporting ingredient for growth in various cell culture processes. Moreover, it is also used in improving cell proliferation and promoting the production of therapeutic proteins for several applications. It is often employed in advanced therapies and vaccines. Additionally, it is broadly used in research and drug testing to learn more about insulin functions and glucose metabolism.
The market for recombinant human insulin is majorly driven by its applications in the medical and healthcare industries to regulate blood sugar levels in diabetic patients, which fuels its market growth. Moreover, its employment in advanced therapies further enhances its demand in the medical industry.
Its application in pharmacological studies and biotechnological research remarkably boosts its demand in the biotechnology, genetic engineering, research & development industries. Additionally, several factors influence industrial recombinant human insulin procurement, such as the source and purity, cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Recombinant Human Insulin Production
According to the Recombinant Human Insulin manufacturing plant project report, the major raw material for Recombinant Human Insulin production includes Rhizobium japonicum.
Manufacturing Process of Recombinant Human Insulin
The extensive Recombinant Human Insulin production cost report consists of the following industrial manufacturing process:
- Production from E.coli Bacteria: This method of producing recombinant human insulin involves inserting the insulin gene and a promoter region of the lac operon on the plasmids of E. coli. Here, E. coli is placed in a mixture containing carbon, nitrogen, and phosphorus, which is essential for its growth during the fermentation process. The fermentation process takes place in a bioreactor, where the parameters can be controlled for maximum cell growth and insulin production.
Recombinant Human Insulin is a clear and colourless, water-soluble solution and consists of 51- amino acids. It appears as a white to off-white crystalline substance in its pure form. The chemical formula of the compound is C257H383N65O77S6 and molecular weight is 5.81 kDa. It was first manufactured in 1983 by an American Biotech company. Moreover, its melting point is 233°C and its density is 1.09 g/cm3.
The molecular structure of human insulin is a combination of two peptide chains (dimer), A-chain and B-chain that are linked together by two disulfide bonds. Its storage temperature is around -20°C. Its trademark name is Humulin.
Product Details
| Particulars | Details |
|---|---|
| Product Name | Recombinant Human Insulin |
| Scope | Manufacturing Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
Key Questions Answered in This Report
- What are the key requirements for setting up a recombinant human insulin manufacturing plant?
- How is recombinant human insulin manufactured?
- What is the process flow involved in producing recombinant human insulin?
- What are the raw material requirements and costs for producing recombinant human insulin?
- What is the total size of land required for setting up a recombinant human insulin manufacturing plant?
- What are the construction requirements for setting up a recombinant human insulin manufacturing plant?
- What are the machinery requirements for producing recombinant human insulin?
- What are the utility requirements and costs for producing recombinant human insulin?
- What are the manpower requirements for producing recombinant human insulin?
- What are the average salaries/wages of manpower working in a recombinant human insulin manufacturing plant?
- What are the packaging requirements and associated costs for recombinant human insulin?
- What are the transportation requirements and associated costs for recombinant human insulin?
- What are the capital costs for setting up a recombinant human insulin manufacturing plant?
- What are the operating costs for setting up a recombinant human insulin manufacturing plant?
- What should be the price of recombinant human insulin?
- What will be the income and expenditures for a recombinant human insulin manufacturing plant?
Need more help?
- We can tailor the report as per your unique requirements such as desired capacity, future expansion plans, product specifications, mode of financing, plant location, etc.
- We can also provide a flexible, easy-to-use, dynamic excel-based cost-model/ dashboard where you can change the inputs to get different outputs
- Speak to our highly skilled team of analysts for insights on the recent trends and innovations, industry best practices, key success and risk factors, product pricing, margins, return on investment, industry standards and regulations, etc.
- Gain an unparalleled competitive advantage in your domain by understanding how to optimize your business operations and maximize profits
- For further assistance, please connect with our analysts